Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Rabbit Polyclonal to Human SELL / L-Selectin / CD62L
Human, Mouse, Rat
Western blot, Immunoprecipitation (applications tested for the base form of this product only)
Magnetic beads Conjugated
Human SELL / L-Selectin / CD62L
Human, Mouse, Rat (tested or 100% immunogen sequence identity)
(applications tested for the base form of this product only)
Specificity and Use
SELL / L-Selectin / CD62L antibody was raised against synthetic peptide corresponding to a sequence at the middle region of human L-selectin (125-141 aa), identical to the related mouse and rat sequence.
Rat. No cross reactivity with other proteins.
The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.
1 mg/ml magnetic beads in PBS, pH 7.2, 0.05 mg sodium azide
SELL / L-Selectin / CD62L is a cell surface adhesion molecule that belongs to a family of adhesion/homing receptors. The encoded protein contains a C-type lectin-like domain, a calcium-binding epidermal growth factor-like domain, and two short complement-like repeats. The gene product is required for binding and subsequent rolling of leucocytes on endothelial cells, facilitating their migration into secondary lymphoid organs and inflammation sites.